Related Experiment Video
Updated: Apr 27, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
ANA fluorescence patterns and low C4 are associated with higher antiphospholipid antibody serological intensity in
Nikolaos Androulakis1, Olga Striligka1, Eleni Nioti1
1Hematology Laboratory, University Hospital of Iraklion, Iraklion, Greece.
Objectives:
To evaluate whether antinuclear antibody (ANA) titre or HEp-2 fluorescence patterns are associated with antiphospholipid antibody (aPL) serological intensity, and to examine component-specific complement abnormalities - particularly low C4 - as laboratory correlates compatible with classical-pathway involvement.
Methods:
This retrospective cross-sectional study analysed 626 consecutive diagnostic samples with same-day testing for lupus anticoagulant (LA), anticardiolipin (aCL), anti-β2-glycoprotein I (anti-β2GPI) antibodies, and ANA. aPL serological intensity was categorised from 0 to 3 (negative to triple-positive) using predefined laboratory cut-offs. ANA patterns were grouped as negative, homogeneous, speckled, or other. Complement variables included low C3, low C4, and combined hypocomplementaemia. Associations were assessed using ordered logistic regression, with Firth bias-reduced logistic regression applied for binary outcomes with sparse events.
Results:
Overall, 26.5 % of samples (166/626) were aPL-positive, including 1.6 % triple-positive cases (10/626). High-titre ANA (≥1:160) was not associated with higher aPL serological intensity (OR 1.00, 95 % CI 0.51-1.96). In contrast, homogeneous (OR 1.99, 95 % CI 1.26-3.18) and speckled (OR 2.85, 95 % CI 1.66-4.91) ANA patterns were independently associated with higher aPL categories. Low C4, - but not low C3 - was associated with aPL positivity in binary analysis (Firth OR 6.84, p=0.001; low-C4 events n=10).
Conclusions:
ANA fluorescence patterns, but not ANA titre, are associated with higher aPL serological intensity, indicating a distinct laboratory serological phenotype. Low C4 shows an association compatible with classical-pathway complement involvement. These findings are observational and require validation in longitudinal studies.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014